FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.464.1003.110.11.1115
| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | 2.16.840.1.113883.3.464.1003.110.11.1115 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.110.11.1115/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1115 |
| Version | 20230215 |
| Status | active |
| Date | 2023-02-15T01:02:57-05:00 |
| Name | ChildInfluenzaVaccineAdministered |
| Title | Child Influenza Vaccine Administered |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for an influenza vaccination.),(Data Element Scope: This value set may use a model element related to Procedure for use in children 2 and younger.),(Inclusion Criteria: Includes concepts that represent an influenza vaccination for use in children 2 and younger.),(Exclusion Criteria: Excludes influenza vaccines not recommended for use in children 2 and younger.) |
Resources that use this resource
Resources that this resource uses
| CodeSystem |
| cpt | Current Procedural Terminology (CPT®) |
Narrative
No narrative content found in resource
Source
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113883.3.464.1003.110.11.1115",
"meta": {
"versionId": "32",
"lastUpdated": "2023-12-21T17:43:03.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "NCQA PHEMUR Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-02-03"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2023-02-15"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1115",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.3.464.1003.110.11.1115"
}
],
"version": "20230215",
"name": "ChildInfluenzaVaccineAdministered",
"title": "Child Influenza Vaccine Administered",
"status": "active",
"date": "2023-02-15T01:02:57-05:00",
"publisher": "NCQA PHEMUR",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for an influenza vaccination.),(Data Element Scope: This value set may use a model element related to Procedure for use in children 2 and younger.),(Inclusion Criteria: Includes concepts that represent an influenza vaccination for use in children 2 and younger.),(Exclusion Criteria: Excludes influenza vaccines not recommended for use in children 2 and younger.)",
"compose": {
"include": [
{
"system": "http://www.ama-assn.org/go/cpt",
"concept": [
{
"code": "90655",
"display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
},
{
"code": "90657",
"display": "Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"
},
{
"code": "90661",
"display": "Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
},
{
"code": "90673",
"display": "Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
},
{
"code": "90674",
"display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
},
{
"code": "90685",
"display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
},
{
"code": "90686",
"display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
},
{
"code": "90687",
"display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"
},
{
"code": "90688",
"display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"
},
{
"code": "90689",
"display": "Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use"
},
{
"code": "90756",
"display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:0e9702ea-0e0a-42a1-acc9-07a0f35cbb5e",
"timestamp": "2025-05-23T22:16:15-04:00",
"total": 11,
"contains": [
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90655",
"display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90657",
"display": "Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90661",
"display": "Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90673",
"display": "Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90674",
"display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90685",
"display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90686",
"display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90687",
"display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90688",
"display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90689",
"display": "Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90756",
"display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"
}
]
}
}
FHIR